Horizon Therapeutics (HZNP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
116.30 +0.05 (+0.04%) 10/05/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 116.30 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 3,629,044 | 3,226,410 | 2,200,429 | 1,300,029 | 1,207,570 |
| Cost of Goods | 920,197 | 794,512 | 532,695 | 362,175 | 391,301 |
| Gross Profit | 2,708,847 | 2,431,898 | 1,667,734 | 937,854 | 816,269 |
| Operating Expenses | 2,091,632 | 1,889,283 | 1,178,403 | 811,418 | 778,659 |
| Operating Income | 617,412 | 543,127 | 490,026 | 126,611 | 37,911 |
| Interest Expense | 83,707 | 81,063 | 59,616 | 87,089 | 121,692 |
| Other Income | -6,769 | 763 | -28,765 | -59,746 | 649 |
| Pre-tax Income | 526,936 | 462,827 | 401,645 | -20,224 | -83,132 |
| Income Tax | 5,454 | -71,664 | 11,849 | -593,244 | -44,752 |
| Net Income Continuous | 521,482 | 534,491 | 389,796 | 573,020 | -38,380 |
| Net Income | $521,482 | $534,491 | $389,796 | $573,020 | $-38,380 |
| EPS Basic Total Ops | 2.28 | 2.37 | 1.91 | 3.13 | -0.23 |
| EPS Basic Continuous Ops | 2.28 | 2.37 | 1.91 | 3.13 | -0.23 |
| EPS Diluted Total Ops | 2.22 | 2.27 | 1.81 | 2.90 | -0.23 |
| EPS Diluted Continuous Ops | 2.22 | 2.27 | 1.81 | 2.79 | -0.23 |
| EPS Diluted Before Non-Recurring Items | 4.86 | 4.62 | 3.88 | 1.94 | 1.83 |
| EBITDA(a) | $1,071,888 | $902,067 | $782,117 | $386,370 | $310,421 |